Patients

What happens to your answers during clinical trial prescreening?

A patient-friendly privacy guide explaining how prescreen answers support study review, why they are not public, and what patients should avoid sharing in public forms.

Prescreen answers help a study team understand possible fit. They should be handled through secure workflows and are not meant to be public posts or open website comments.

In this guide

Key points

  • Prescreen answers are used to support early study review, not to make final eligibility decisions by themselves.
  • Patients should avoid putting sensitive medical details into public contact forms or non-secure messages.
  • Authorized study teams may ask follow-up questions before confirming screening or enrollment next steps.

Why prescreen answers are collected

Clinical trial prescreening collects basic fit signals so a study team can decide whether a study may be worth discussing with a patient.

Those answers can include condition area, age range, visit preferences, travel distance, availability, and study-specific screening context.

What privacy means in this step

Prescreen answers are not intended to become public information. They should move through secure account and coordinator workflows, not open comment boxes or general marketing forms.

A prescreen is also not a diagnosis, medical advice, or enrollment decision. It is an early review step before authorized study-team follow-up.

How patients can share safely

Use the study application or secure patient workspace when sharing study-specific details. Use public contact forms only for general questions.

If a coordinator needs more information, they can explain what is needed and how to provide it through the appropriate study workflow.

What should stay out of public forms

Patients should avoid placing detailed medical history, medication lists, documents, dates of birth, insurance information, or urgent health concerns into general contact forms. Those details belong in the secure study application or coordinator workflow when the site asks for them.

A privacy-aware page should tell patients which path is meant for general questions and which path is meant for study-specific information. That distinction makes the next step clearer and helps avoid oversharing before the appropriate workflow is available.

How sites should explain review boundaries

Research sites can build trust by explaining that prescreen answers support early review, not final eligibility. A coordinator may use the answers to decide whether more information, records, a call, or another study path makes sense.

That language keeps patient expectations grounded. It also reinforces that authorized study teams, not a public form or matching tool, decide final screening and enrollment steps after the required review.

Common questions

Should I include health details in a general contact form?

Use the study’s appropriate application or patient workspace for requested information. General support forms are for general questions.

Sources and editorial notes

Published .

This guide explains recruitment work and questions to discuss with your team.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

Study information

Have questions about taking part?

Review study information and ask the study team about visits, screening, and what happens next.

Keep reading